Roche's Mircera Banned From U.S. In Amgen's Win
By Allison Grande · December 23, 2009, 2:40 PM EST
A federal judge has enjoined Swiss drugmaker Hoffmann-La Roche Inc. from selling its anemia drug Mircera in the U.S. until mid-2014 following a settlement Roche reached with Amgen Inc. admitting that...
To view the full article, register now.